Shandong Sinobioway Biomedicine announced that the company will publicly list the sale of its wholly-owned subsidiary Weiming Tianyuan's 26.8380% equity in Yingkou Chemical at the Shandong Property Exchange Center. Recently, Weiming Tianyuan signed the "Equity Transfer Agreement for Yingkou Xingxin Chemical Technology Co., Ltd." with Yingkou Shenghai, Malion New Materials, and Yingkou Chemical regarding the transfer of equity in this shareholding company, with a transfer price of 74.0254 million yuan. Upon completion of this trade, the company will no longer hold equity in Yingkou Chemical. This trade aligns with the company's current operational situation and development global strategy, benefiting the optimization of the asset structure.